Science Applications Financial Statements (SAIC)
|
|
|
|
Report date
|
|
|
28.03.2022 |
03.04.2023 |
20.03.2024 |
17.03.2025 |
16.03.2026 |
|
16.03.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
7 394 |
7 704 |
7 444 |
7 479 |
7 262 |
|
7 262 |
|
Operating Income, bln rub |
|
|
462.0 |
501.0 |
741.0 |
563.0 |
515.0 |
|
517.0 |
|
EBITDA, bln rub |
? |
|
628.0 |
650.0 |
882.0 |
694.0 |
664.0 |
|
660.0 |
|
Net profit, bln rub |
? |
|
277.0 |
300.0 |
477.0 |
362.0 |
358.0 |
|
358.0 |
|
|
OCF, bln rub |
? |
|
518.0 |
532.0 |
396.0 |
494.0 |
609.0 |
|
609.0 |
|
CAPEX, bln rub |
? |
|
36.0 |
25.0 |
27.0 |
36.0 |
32.0 |
|
38.0 |
|
FCF, bln rub |
? |
|
482.0 |
507.0 |
369.0 |
458.0 |
577.0 |
|
609.0 |
|
Dividend payout, bln rub
|
|
|
86.0 |
83.0 |
79.0 |
75.0 |
70.0 |
|
70.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
31.0% |
27.7% |
16.6% |
20.7% |
19.6% |
|
19.6% |
|
|
OPEX, bln rub |
|
|
397.0 |
387.0 |
131.0 |
329.0 |
357.0 |
|
355.0 |
|
Cost of production, bln rub |
|
|
6 535 |
6 816 |
6 572 |
6 587 |
6 390 |
|
6 390 |
|
R&D, bln rub |
|
|
4.00 |
1.000 |
4.00 |
12.0 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
105.0 |
118.0 |
120.0 |
126.0 |
128.0 |
|
128.0 |
|
|
Assets, bln rub |
|
|
5 746 |
5 543 |
5 314 |
5 246 |
5 354 |
|
5 354 |
|
Net Assets, bln rub |
? |
|
1 619 |
1 694 |
1 785 |
1 577 |
1 500 |
|
1 500 |
|
Debt, bln rub |
|
|
2 710 |
2 526 |
2 246 |
2 393 |
2 706 |
|
2 706 |
|
Cash, bln rub |
|
|
106.0 |
109.0 |
94.0 |
56.0 |
182.0 |
|
182.0 |
|
Net debt, bln rub |
|
|
2 604 |
2 417 |
2 152 |
2 337 |
2 524 |
|
2 524 |
|
|
Ordinary share price, rub |
|
|
82.0 |
103.8 |
127.7 |
108.3 |
101.8 |
|
101.8 |
|
Number of ordinary shares, mln |
|
|
57.6 |
55.3 |
53.1 |
50.1 |
46.3 |
|
45.0 |
|
|
Market cap, bln rub |
|
|
4 725 |
5 739 |
6 779 |
5 425 |
4 711 |
|
4 579 |
|
EV, bln rub |
? |
|
7 329 |
8 156 |
8 931 |
7 762 |
7 235 |
|
7 103 |
|
Book value, bln rub |
|
|
-2 426 |
-2 226 |
-1 960 |
-2 053 |
-2 205 |
|
-2 205 |
|
|
EPS, rub |
? |
|
4.81 |
5.42 |
8.98 |
7.23 |
7.73 |
|
7.96 |
|
FCF/share, rub |
|
|
8.37 |
9.17 |
6.95 |
9.14 |
12.5 |
|
13.5 |
|
BV/share, rub |
|
|
-42.1 |
-40.3 |
-36.9 |
-41.0 |
-47.6 |
|
-49.0 |
|
|
EBITDA margin, % |
? |
|
8.49% |
8.44% |
11.8% |
9.28% |
9.14% |
|
9.09% |
|
Net margin, % |
? |
|
3.75% |
3.89% |
6.41% |
4.84% |
4.93% |
|
4.93% |
|
FCF yield, % |
? |
|
10.2% |
8.83% |
5.44% |
8.44% |
12.2% |
|
13.3% |
|
ROE, % |
? |
|
17.1% |
17.7% |
26.7% |
23.0% |
23.9% |
|
23.9% |
|
ROA, % |
? |
|
4.82% |
5.41% |
8.98% |
6.90% |
6.69% |
|
6.69% |
|
|
P/E |
? |
|
17.1 |
19.1 |
14.2 |
15.0 |
13.2 |
|
12.8 |
|
P/FCF |
|
|
9.80 |
11.3 |
18.4 |
11.8 |
8.17 |
|
7.52 |
|
P/S |
? |
|
0.64 |
0.74 |
0.91 |
0.73 |
0.65 |
|
0.63 |
|
P/BV |
? |
|
-1.95 |
-2.58 |
-3.46 |
-2.64 |
-2.14 |
|
-2.08 |
|
EV/EBITDA |
? |
|
11.7 |
12.5 |
10.1 |
11.2 |
10.9 |
|
10.8 |
|
Debt/EBITDA |
|
|
4.15 |
3.72 |
2.44 |
3.37 |
3.80 |
|
3.82 |
|
|
R&D/CAPEX, % |
|
|
11.1% |
4.00% |
14.8% |
33.3% |
0.00% |
|
0.00% |
|
|
CAPEX/Revenue, % |
|
|
0.49% |
0.32% |
0.36% |
0.48% |
0.44% |
|
0.52% |
|
| Science Applications shareholders |
